Hazard rate for postoperative recurrence in patients with hepatocellular carcinoma at Barcelona Clinic Liver Cancer stage 0 or A1: A multicenter observational study.
Yan-Jun XiangKang WangHong-Ming YuMiao-Miao WangLe-Qun LiHui-Chuan SunTian-Fu WenYu-Qing ZhangYun-Feng ShanLi-Ping ZhouShu-Qun ChengPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2022)
A short-interval follow-up of 1 year is sufficient for HCC patients with BCLC stage 0 disease, whereas a short-interval follow-up time of 3 years should be considered for patients with stage A1 disease. The follow-up period should be appropriately prolonged for patients with cirrhosis, HBV infection, and satellite lesions.